CLINICAL_TRIALS
research
· 2014-07-11
Clinical Trial Update: A Long-term Study of Ba253BINEB in Patients With Bronchial Asthma [Phase 3]
Summary
A long-term Phase 3 trial evaluating Ba253BINEB in patients with asthma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 3 | Status: COMPLETED